AlphaFold 3 Solves Protein-Drug Interaction Problem

This extension to DNA, RNA, and small molecules identified over 200 drug candidates in a year, accelerating timelines from years to months. Concrete data from pharmaceutical partners shows 40% cost reduction per target, a 30% improvement over AlphaFold 2, transforming drug discovery with unprecedented precision.